0 Commentarii
0 Distribuiri
498 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Biologics & Precision Oncology: Prescription Drugs Market Set for Steady 6.76% CAGR Through 2032Global Prescription Drugs Market Poised to Surpass USD 2,444.22 Billion by 2032 Driven by Biologics Innovation, Next-Generation Targeted Therapies, and Rising Chronic Disease Prevalence The global pharmaceutical and clinical healthcare landscape is undergoing an unprecedented therapeutic and structural transformation. Driven by rapid breakthroughs in molecular biology, targeted genomics,...0 Commentarii 0 Distribuiri 235 Views 0 previzualizare
-
Biologics Market Size, Share & Growth ReportGlobal Biologics Market Poised for Exponential Growth as Targeted Therapies, Precision Oncology, and Advanced Biomanufacturing Reshape Modern Medicine 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @ https://www.maximizemarketresearch.com/request-sample/37255/ The global pharmaceutical landscape is experiencing an unprecedented structural shift from conventional small-molecule synthetic chemical synthesis to highly...0 Commentarii 0 Distribuiri 412 Views 0 previzualizare
-
Cell-Free Biologics Market Forecast Highlights 8.3% CAGR Through 2036October 3, 2026 — The Cell-Free Biologics Market is projected to reach USD 1.16 billion by 2036, rising from USD 0.53 billion in 2026 at a CAGR of 8.3%, according to Fact.MR analysis. The market was valued at USD 0.49 billion in 2025, with an absolute dollar opportunity of USD 0.63 billion expected between 2026 and 2036. The market is expanding through early-stage commercial adoption...0 Commentarii 0 Distribuiri 349 Views 0 previzualizare
-
Inflammatory Bowel Disease Biologics Market to Approach USD 130.8 Billion by 2036, India - CAGR 10.1%, China - CAGR 9.9%, Germany - CAGR 7.9%The inflammatory bowel disease biologics market is forecast to expand from USD 60.73 billion in 2026 to USD 130.81 billion by 2036, registering an 8.0% CAGR over the forecast period. Fact.MR attributes this expansion to the rising prevalence and diagnosis of inflammatory bowel disease, increasing adoption of biologics for moderate-to-severe cases, and the continued introduction of therapies...0 Commentarii 0 Distribuiri 247 Views 0 previzualizare
-
Orthopedic Trauma Devices Market – Biologics Integration Enhancing Fracture Healing in High-Risk Nonunion PopulationsMarket Overview The orthopedic trauma devices market is increasingly integrating biologics such as bone morphogenetic proteins, platelet-rich plasma, and mesenchymal stem cell concentrates to enhance fracture healing in high-risk nonunion populations. Surgeons are combining biologics with fixation devices to address biological insufficiency in smokers, diabetics, and elderly patients with...0 Commentarii 0 Distribuiri 438 Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek
